CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 2,230 shares at $1.93 ($4,304)
- 4 Open-market sale SVP, FINANCE AND CAO sold 573 shares at $1.93 ($1,106)
- 4 Open-market sale SVP, FINANCE AND CAO sold 1,404 shares at $2.04 ($2,864)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 12,311 shares at $2.17 ($26,715)
- 4 Open-market sale SVP, FINANCE AND CAO sold 903 shares at $2.17 ($1,960)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, FINANCE AND CAO sold 565 shares at $2.27 ($1,283)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 2,201 shares (to pay taxes)
- 4 Open-market buy Director bought 3,184,713 shares at $1.57 ($4,999,999)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 11 · 213 filings